ALX three-lens brief
Evidence-based stock research on ALX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 8.7pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 8.7pp over 30 days.
- P/E of 7.8 — trading at a value multiple.
- Debt-to-equity of 383% — balance-sheet-heavy.
ALX closed at $253.30 (-1.75%) as of 2026-09-11. Market cap: $1.29B. P/E (trailing) 7.8. Price is below the 50-day MA and above the 200-day MA. Positives: p/E of 7.8 — trading at a value multiple.. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 8.7pp over 30 days.. Last quarter: Revenue $54.71M, net income $155.36M, free cash flow $45.69M.
Why three lenses on ALX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALX brief"></iframe>